Global HCAI Control Market 2022 - Industry Briefing
The global HCAI control market size is projected to grow by USD 15 billion from 2022 to 2028, registering a CAGR of 8.1 percent, according to a new report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the type, and region. The global market data on HCAI control can be segmented by type: environment sterilization, medical devices, pharmaceuticals. The environment sterilization segment held the largest share of the global HCAI control market in 2021 and is anticipated to hold its share during the forecast period. HCAI control market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). Globally, North America made up the largest share of the HCAI control market.
The medical devices market is further segmented into coated catheters, coated endotracheal tubes (ETTs), intravenous (IV) filters. In 2021, the coated catheters segment made up the largest share of revenue generated by the HCAI control market. Furthermore, the pharmaceuticals market has been categorized into antibiotics, antifungals, antivirals, vaccines. Among these, the antibiotics segment was accounted for the highest revenue generator in 2021. The environment sterilization market is further divided into disinfectants, environment sterilization, skin preparation. The disinfectants segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period.
The global HCAI control market is highly competitive. The HCAI control market is dominated by key players, which are 3M Company, Bactiguard Holding AB, Becton Dickinson and Company (BD), Belimed AG, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A., Seqirus Inc., Teleflex Incorporated, The Clorox Company.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
This industry report offers market estimates of the global market, followed by a detailed analysis of the type, and region. The global market data on HCAI control can be segmented by type: environment sterilization, medical devices, pharmaceuticals. The environment sterilization segment held the largest share of the global HCAI control market in 2021 and is anticipated to hold its share during the forecast period. HCAI control market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). Globally, North America made up the largest share of the HCAI control market.
The medical devices market is further segmented into coated catheters, coated endotracheal tubes (ETTs), intravenous (IV) filters. In 2021, the coated catheters segment made up the largest share of revenue generated by the HCAI control market. Furthermore, the pharmaceuticals market has been categorized into antibiotics, antifungals, antivirals, vaccines. Among these, the antibiotics segment was accounted for the highest revenue generator in 2021. The environment sterilization market is further divided into disinfectants, environment sterilization, skin preparation. The disinfectants segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period.
The global HCAI control market is highly competitive. The HCAI control market is dominated by key players, which are 3M Company, Bactiguard Holding AB, Becton Dickinson and Company (BD), Belimed AG, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A., Seqirus Inc., Teleflex Incorporated, The Clorox Company.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
- Get a detailed picture of the Global HCAI Control Market
- Identify segments/areas to invest in over the forecast period in the Global HCAI Control Market
- Understand the competitive environment, the market’s leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
PART 1. SUMMARY
PART 2. INTRODUCTION
Study period
Geographical scope
Market segmentation
PART 3. HCAI CONTROL MARKET OVERVIEW
PART 4. MARKET BREAKDOWN BY TYPE
Environment sterilization
Medical devices
Pharmaceuticals
PART 5. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 6. KEY COMPANIES
3M Company
Bactiguard Holding AB
Becton, Dickinson and Company (BD)
Belimed AG
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
Merck KGaA
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Seqirus Inc.
Teleflex Incorporated
The Clorox Company
PART 7. METHODOLOGY
PART 2. INTRODUCTION
Study period
Geographical scope
Market segmentation
PART 3. HCAI CONTROL MARKET OVERVIEW
PART 4. MARKET BREAKDOWN BY TYPE
Environment sterilization
Medical devices
Pharmaceuticals
PART 5. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 6. KEY COMPANIES
3M Company
Bactiguard Holding AB
Becton, Dickinson and Company (BD)
Belimed AG
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
Merck KGaA
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Seqirus Inc.
Teleflex Incorporated
The Clorox Company
PART 7. METHODOLOGY
